Investors

SPARK Ventures
www.sparkventures.com

SPARK Ventures is the leading quoted early-stage venture capital company in Europe. It manages over £240m on behalf of major institutional investors, leading UK universities, and three quoted venture capital trusts. SPARK invests in entrepreneurs to create dynamic businesses in the technology, media, telecoms and healthcare & life sciences sectors. As well as capital, it brings a wealth of experience of developing high growth companies from early stage through to IPO or trade sale, adding value to its investments through active support and strategic direction. SPARK Ventures is the lead investor in Haemostatix.

Catapult Venture Managers Limited
www.catapult-vm.co.uk

Catapult Venture Managers Limited (Catapult) has £80m of funds under management and specializes in providing equity capital for businesses requiring between £200k and £2m. Catapult invests in all stages of the business lifecycle including early stage, development capital and MBO/MBIs. Catapult invests in most sectors, but has a particular interest in healthcare, medical devices, environmental and support services.

NESTA
www.nesta.org.uk

NESTA is the National Endowment for Science, Technology & the Arts - a unique body with a mission to make the UK more innovative. NESTA invests in early-stage companies, informs and shapes policy, and delivers practical programmes that inspire others to solve the big challenges of the future. NESTA has endowed funds of over £300m.

Lachesis Fund
www.lboro.ac.uk/business/Lachesis

The Lachesis Fund was established with £3m from the Government's University Challenge Seed Fund Scheme and with an additional £1m from the Universities of De Montfort, Leicester, Loughborough, Nottingham and Nottingham Trent. The Fund fills the ‘seed-corn’ funding gap that exists for very early stage technologies in the higher education sector. Its portfolio of investments has a strong bio-medical, engineering and materials focus, reflecting the expertise of the partner universities.